19.97
Precedente Chiudi:
$19.98
Aprire:
$20.3
Volume 24 ore:
11.06M
Relative Volume:
1.59
Capitalizzazione di mercato:
$19.05B
Reddito:
$9.79B
Utile/perdita netta:
$-395.51M
Rapporto P/E:
-47.97
EPS:
-0.4163
Flusso di cassa netto:
$-3.55B
1 W Prestazione:
+15.30%
1M Prestazione:
+11.32%
6M Prestazione:
-4.31%
1 anno Prestazione:
-21.22%
Xpeng Inc Adr Stock (XPEV) Company Profile
Nome
Xpeng Inc Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare XPEV vs TSLA, TM, GM, RACE, F
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
XPEV
Xpeng Inc Adr
|
19.97 | 19.05B | 9.79B | -395.51M | -3.55B | -0.4163 |
|
TSLA
Tesla Inc
|
391.20 | 1.47T | 94.83B | 3.86B | 6.22B | 1.076 |
|
TM
Toyota Motor Corporation Adr
|
210.84 | 274.80B | 337.18B | 25.73B | 300.48M | 18.92 |
|
GM
General Motors Company
|
72.39 | 65.44B | 185.02B | 2.78B | 1.77B | 3.0106 |
|
RACE
Ferrari N V
|
331.86 | 58.72B | 8.07B | 1.81B | 1.64B | 10.10 |
|
F
Ford Motor Co
|
11.67 | 46.56B | 187.27B | -8.16B | 12.47B | -1.9158 |
Xpeng Inc Adr Stock (XPEV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-18 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2025-08-18 | Iniziato | BNP Paribas Exane | Neutral |
| 2025-06-17 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-05-21 | Aggiornamento | Macquarie | Neutral → Outperform |
| 2025-03-19 | Downgrade | Daiwa Securities | Buy → Neutral |
| 2025-03-19 | Aggiornamento | Nomura | Neutral → Buy |
| 2025-03-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-02-24 | Aggiornamento | UBS | Sell → Neutral |
| 2025-02-07 | Downgrade | Macquarie | Outperform → Neutral |
| 2024-12-05 | Downgrade | UBS | Neutral → Sell |
| 2024-11-22 | Aggiornamento | China Renaissance | Hold → Buy |
| 2024-11-21 | Downgrade | Goldman | Buy → Neutral |
| 2024-09-05 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-08-30 | Aggiornamento | Macquarie | Neutral → Outperform |
| 2024-06-25 | Aggiornamento | Citigroup | Sell → Neutral |
| 2024-05-23 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2024-04-15 | Ripresa | Macquarie | Neutral |
| 2023-08-21 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-08-08 | Aggiornamento | CLSA | Outperform → Buy |
| 2023-08-07 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2023-07-31 | Downgrade | UBS | Buy → Neutral |
| 2023-07-27 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-07-27 | Aggiornamento | Macquarie | Underperform → Outperform |
| 2023-07-21 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-07-11 | Iniziato | Goldman | Buy |
| 2023-06-30 | Downgrade | CLSA | Buy → Outperform |
| 2023-05-25 | Downgrade | Barclays | Equal Weight → Underweight |
| 2023-04-25 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-02-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2023-01-11 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-01-06 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-12-14 | Downgrade | Daiwa Securities | Buy → Sell |
| 2022-11-28 | Downgrade | Jefferies | Hold → Underperform |
| 2022-11-17 | Aggiornamento | UBS | Neutral → Buy |
| 2022-10-28 | Downgrade | Citigroup | Buy → Sell |
| 2022-08-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-08-03 | Downgrade | Macquarie | Outperform → Neutral |
| 2022-07-01 | Downgrade | Nomura | Buy → Neutral |
| 2022-05-25 | Iniziato | Macquarie | Outperform |
| 2022-04-01 | Iniziato | HSBC Securities | Buy |
| 2022-03-24 | Iniziato | China Renaissance | Buy |
| 2022-03-23 | Iniziato | CLSA | Buy |
| 2022-02-08 | Iniziato | Barclays | Overweight |
| 2022-01-12 | Iniziato | Macquarie | Outperform |
| 2021-10-28 | Iniziato | Bernstein | Outperform |
| 2021-05-26 | Iniziato | Nomura | Buy |
| 2021-03-09 | Aggiornamento | Daiwa Securities | Sell → Buy |
| 2021-01-29 | Iniziato | Morgan Stanley | Overweight |
| 2021-01-19 | Iniziato | Jefferies | Hold |
| 2020-12-14 | Iniziato | Deutsche Bank | Buy |
| 2020-12-03 | Downgrade | UBS | Buy → Neutral |
| 2020-11-04 | Iniziato | Citigroup | Buy |
| 2020-09-25 | Iniziato | UBS | Buy |
| 2020-09-22 | Iniziato | JP Morgan | Overweight |
| 2020-09-21 | Iniziato | BofA Securities | Buy |
Mostra tutto
Xpeng Inc Adr Borsa (XPEV) Ultime notizie
XPeng, Inc. ADR Jumps as Wall Street Hails Self-Driving - TipRanks
XPENG Inc. Sponsored ADR (NYSE:XPEV) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
XPeng, Inc. Class A (9868) Receives a Buy from CICC - The Globe and Mail
Will Higher Gas Prices Really Boost EV Sales? - The Motley Fool
Why Xpeng Stock Was Winning This Week - The Globe and Mail
Volkswagen Begins Mass Production for 1st Car Developed with XPENG-W - AASTOCKS.com
XPENG (XPEV) Projected to Post Earnings on Friday - MarketBeat
Stellantis Said to Be Interested in Bringing CN Automakers into European Biz, Once Holds Talks with XIAOMI-W/ XPENG-W - AASTOCKS.com
XPeng to Launch VLA 2.0 Autonomous Driving Platform in 2027 - TradingView
CMSI Optimistic About XPENG-W (09868.HK) Smart Driving Segment, Keeps Overweight Rating - AASTOCKS.com
XPeng (XPEV) Is Considered a Good Investment by Brokers: Is That True? - Finviz
XPeng (XPEV) Viewed Favorably by Analysts: Does the Claim Hold Up? - Bitget
XPENG (NYSE:XPEV) Sees Large Volume IncreaseShould You Buy? - MarketBeat
Why XPeng, Inc. ADR Shares Are Surging Now - TipRanks
Huatai Securities Remains a Buy on XPeng, Inc. Class A (9868) - The Globe and Mail
XPeng (XPEV) Soars Ahead of Earnings; Q4 Deliveries Fall Short - Finviz
Buy, Hold or Sell NIO Stock? Key Insights Ahead of Q4 Earnings - Finviz
Analysts’ Opinions Are Mixed on These Consumer Cyclical Stocks: XPeng, Inc. ADR (XPEV), Ulta Beauty (ULTA) and ChargePoint Holdings (CHPT) - The Globe and Mail
XPeng Inc. Board Meeting and Q4/Fiscal Year 2025 Earnings Release, Conference Call Details Announced - Minichart
XPeng (XPEV) plans March 20, 2026 board meeting and earnings call - Stock Titan
Analysts Conflicted on These Consumer Cyclical Names: XPeng, Inc. ADR (XPEV) and Norwegian Cruise Line (NCLH) - The Globe and Mail
He Xiaopeng: XPENG-W to Skip L3-lv. Autonomous Driving, Directly Deploy L4 Mass Production; Annual R&D Investment Expected to Be >RMB4.5B - AASTOCKS.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XPeng Inc.XPEV - ChartMill
XPENG (NYSE:XPEV) Sets New 52-Week LowWhat's Next? - MarketBeat
NIO, XPeng & Li Auto Post Delivery Results for February - TradingView
XPeng (NYSE: XPEV) posts 15,256 February EV deliveries, starts P7+ rollout - Stock Titan
XPENG-W Feb New Car Deliveries Drop 49.9% YoY to 15,256 Units - AASTOCKS.com
XPENG Announces Vehicle Delivery Results for February 2026 - The Manila Times
Bank of America Securities Sticks to Its Buy Rating for XPeng, Inc. ADR (XPEV) - The Globe and Mail
XPeng Inc. (XPEV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
What Does the Street Think About XPeng Inc. (XPEV)? - Finviz
Tesla Rival Xpeng Expands Robotics Bet With Guangzhou Factory For Optimus Challenger IRON - Benzinga
Why XPeng, Inc. ADR Shares Are Taking Off - TipRanks
XPeng CEO Targets Doubling Overseas Sales This Yr, 70%+ Profit Contribution from Overseas Mkts by 2030 - AASTOCKS.com
HSBC Research Favors XPENG-W, HORIZONROBOT-W as CN Improving Autonomous Driving Legal Framework - AASTOCKS.com
Citi is Bullish on XPeng Inc. (XPEV) - Finviz
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XPeng Inc. (XPEV) And Encourages Shareholders to Reach Out - ACCESS Newswire
XPeng Inc. (XPEV) Expands Charging and Global EV Presence - Finviz
Wall Street Analysts See XPeng (XPEV) as a Buy: Should You Invest? - Finviz
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against XPeng Inc. (XPEV) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Barclays sees downside risk for XPeng stock after low delivery numbers in January - Investing.com India
Pomerantz Law Firm Investigates Claims On Behalf of Investors of XPeng Inc.XPEV - marketscreener.com
CLSA Slashes XPENG-W's TP to HKD77 as Rising Costs Delay Breakeven - AASTOCKS.com
XPeng (XPEV) Draws Mixed Analyst Calls, Expands Global Payments - Finviz
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against XPeng Inc. (XPEV) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Xpeng Inc Adr Azioni (XPEV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):